Literature DB >> 22829411

Non-operative management of acute cholecystitis in the elderly.

E A McGillicuddy1, K M Schuster, K Barre, L Suarez, M R Hall, G J Kaml, K A Davis, W E Longo.   

Abstract

BACKGROUND: Although cholecystectomy is the standard therapy for acute cholecystitis (AC), operative morbidity in the elderly may be high owing to medical co-morbidities and decreased physiological reserve. Outcomes of AC in the elderly have not been fully defined with regard to operative and long-term non-operative management.
METHODS: Patients aged 65 years or over admitted to a tertiary care centre with a diagnosis of AC between January 2000 and December 2009 were reviewed retrospectively. Patient data, operative and postoperative details were obtained. To determine cholecystectomy rates in the non-operative group, medical records were reviewed, and patients and families were interviewed.
RESULTS: A total of 290 patients underwent cholecystectomy during the index admission, of whom 59 (20·3 per cent) required conversion to open operation. Fifty-eight of these patients experienced 98 complications, including acute respiratory failure (27), pneumonia (18), myocardial infarction (16) and sepsis (15). Some 185 patients had non-operative treatment, of whom 67 underwent percutaneous cholecystostomy. Forty-four patients subsequently had elective cholecystectomy, with a complication rate of 23 per cent. One hundred and twenty-six patients were discharged without a plan for cholecystectomy; the rate of recurrent AC was 4 per cent among the two-thirds of patients followed to within 15 months of death. No deaths or major complications occurred among those with recurrent AC.
CONCLUSION: Despite selection of the best elderly candidates for cholecystectomy, postoperative morbidity was significant. Medical management, with interval cholecystectomy only for recurrent AC, may be appropriate in selected patients.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829411     DOI: 10.1002/bjs.8836

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  24 in total

Review 1.  EUS access to the biliary tree.

Authors:  Manuel Perez-Miranda; Carlos De la Serna-Higuera
Journal:  Curr Gastroenterol Rep       Date:  2013-10

2.  Long-term outcome of patients with acute cholecystitis receiving antibiotic treatment: a retrospective cohort study.

Authors:  Chih-Hung Wang; Hao-Chang Chou; Kao-Lang Liu; Wan-Ching Lien; Hsiu-Po Wang; Yao-Ming Wu
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

3.  Risk-adjusted treatment selection and outcome of patients with acute cholecystitis.

Authors:  J I González-Muñoz; G Franch-Arcas; M Angoso-Clavijo; M Sánchez-Hernández; A García-Plaza; M Caraballo-Angeli; L Muñoz-Bellvís
Journal:  Langenbecks Arch Surg       Date:  2016-10-04       Impact factor: 3.445

4.  The impossible gallbladder: aspiration as an alternative to conversion.

Authors:  Natallia Kharytaniuk; Gary A Bass; Bogdan D Dumbrava; Paul P Healy; Dylan Viani-Walsh; Tej N Tiwary; Tahir Abassi; Matthew P Murphy; Emma Griffin; Thomas N Walsh
Journal:  Surg Endosc       Date:  2019-11-25       Impact factor: 4.584

5.  A nationwide examination of outcomes of percutaneous cholecystostomy compared with cholecystectomy for acute cholecystitis, 1998-2010.

Authors:  Jamie E Anderson; David C Chang; Mark A Talamini
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

6.  Lactobacillus fermentum, a pathogen in documented cholecystitis.

Authors:  Josue Chery; Dmitriy Dvoskin; Fernando P Morato; Bashar Fahoum
Journal:  Int J Surg Case Rep       Date:  2013-05-13

7.  Early laparoscopic cholecystectomy in oldest-old patients: a propensity score matched analysis of a nationwide registry.

Authors:  Marcello Di Martino; Álvaro Gancedo Quintana; Víctor Vaello Jodra; Alfonso Sanjuanbenito Dehesa; Dieter Morales García; Rubén Caiña Ruiz; Francisca García-Moreno Nisa; Fernando Mendoza-Moreno; Sara Alonso Batanero; José Edecio Quiñones Sampedro; Paola Lora Cumplido; Altea Arango Bravo; Ines Rubio-Perez; Luis Asensio-Gomez; Fernando Pardo Aranda; Sara Sentí Farrarons; Cristina Ruiz Moreno; Clara Maria Martinez Moreno; Aingeru Sarriugarte Lasarte; Mikel Prieto Calvo; Daniel Aparicio-Sánchez; Eduardo Perea Perea Del Pozo; Gianluca Pellino; Elena Martin-Perez
Journal:  Updates Surg       Date:  2022-03-06

8.  Severity of Acute Cholecystitis and Risk of Iatrogenic Bile Duct Injury During Cholecystectomy, a Population-Based Case-Control Study.

Authors:  Björn Törnqvist; Anne Waage; Zongli Zheng; Weimin Ye; Magnus Nilsson
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

Review 9.  Conservative treatment of acute cholecystitis: a systematic review and pooled analysis.

Authors:  Charlotte S Loozen; Jelmer E Oor; Bert van Ramshorst; Hjalmar C van Santvoort; Djamila Boerma
Journal:  Surg Endosc       Date:  2016-06-17       Impact factor: 4.584

10.  2013 WSES guidelines for management of intra-abdominal infections.

Authors:  Massimo Sartelli; Pierluigi Viale; Fausto Catena; Luca Ansaloni; Ernest Moore; Mark Malangoni; Frederick A Moore; George Velmahos; Raul Coimbra; Rao Ivatury; Andrew Peitzman; Kaoru Koike; Ari Leppaniemi; Walter Biffl; Clay Cothren Burlew; Zsolt J Balogh; Ken Boffard; Cino Bendinelli; Sanjay Gupta; Yoram Kluger; Ferdinando Agresta; Salomone Di Saverio; Imtiaz Wani; Alex Escalona; Carlos Ordonez; Gustavo P Fraga; Gerson Alves Pereira Junior; Miklosh Bala; Yunfeng Cui; Sanjay Marwah; Boris Sakakushev; Victor Kong; Noel Naidoo; Adamu Ahmed; Ashraf Abbas; Gianluca Guercioni; Nereo Vettoretto; Rafael Díaz-Nieto; Ihor Gerych; Cristian Tranà; Mario Paulo Faro; Kuo-Ching Yuan; Kenneth Yuh Yen Kok; Alain Chichom Mefire; Jae Gil Lee; Suk-Kyung Hong; Wagih Ghnnam; Boonying Siribumrungwong; Norio Sato; Kiyoshi Murata; Takayuki Irahara; Federico Coccolini; Helmut A Segovia Lohse; Alfredo Verni; Tomohisa Shoko
Journal:  World J Emerg Surg       Date:  2013-01-08       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.